ALGN241213C195000
- 0.00
- 0.000.00%
Align Technology Newsroom
Evercore Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $250
Is the Options Market Predicting a Spike in Align Technology (ALGN) Stock?
Strategic Buy Recommendation for Align Technology Amidst Market Recovery and Growth Potential
Align Technology, Inc.'s (NASDAQ:ALGN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Align Technology To Present At 7th Annual Evercore HealthCONx Conference; Webcast At 9:10 AM ET
Mizuho Initiates Align Technology at Outperform With $295 Price Target
Is Wall Street Bullish or Bearish on Align Technology Stock?
Is It Time To Consider Buying Align Technology, Inc. (NASDAQ:ALGN)?
Why Is Align Technology, Inc. (ALGN) Among the Worst Performing Healthcare Stocks in 2024?
Why Is Align Technology (ALGN) Up 5.5% Since Last Earnings Report?
Align Technology Has Received CE Mark In Europe For The Invisalign Palatal Expander System
Express News | Align Technology Has Received Ce Mark in Europe for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients
Align Technology Insiders Sold US$8.4m Of Shares Suggesting Hesitancy
Overweight-rated Companies That Are Focused on 'Operational Efficiency' – MS
Align Technology To Present At Jefferies London Healthcare Conference; Webcast At 7:30 AM ET
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $275
Align Technology To Present At UBS Global Healthcare Conference; Webcast At 11:45 AM ET
Align Technology Hosts the 2024 Invisalign Ortho Summit, Its Premier Education Event to Enhance Digital Practice Transformation and Treatment Experiences for Patients, Teams, and Practices
Evercore Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $250